Position in MRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,624,052
+$1,081,265 QoQ
Shares Held
260,265
+35.7% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. MRVI ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in MRVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,624,052 | 260,265 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $542,787 | 191,798 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,401,512 | 738,927 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $6,885,738 | 2,399,212 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,789,803 | 3,232,284 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,227,550 | 555,453 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,633,729 | 1,951,143 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,939,320 | 233,372 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,195,884 | 167,023 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $780,888 | 90,068 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,005,378 | 153,493 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $572,760 | 57,276 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,758,445 | 141,468 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,594,953 | 113,844 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,297,829 | 90,694 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $2,143,447 | 83,958 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,645,794 | 93,129 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,573,908 | 101,330 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,096,380 | 121,632 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,831,248 | 139,186 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,287,333 | 150,667 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,505,419 | 70,298 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,006,293 | 35,875 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||